ProKidney Corp’s recent filing unveils that its Chief Regulatory Officer Weber Darin J. unloaded Company’s shares for reported $41030.0 on Sep 19 ’24. In the deal valued at $2.50 per share,16,412 shares were sold. As a result of this transaction, Weber Darin J. now holds 103,480 shares worth roughly $0.25 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, DARIN J WEBER bought 16,412 shares, generating $39,225 in total proceeds.
Before that, Weber Darin J. sold 826 shares. ProKidney Corp shares valued at $2,065 were divested by the Chief Regulatory Officer at a price of $2.50 per share. As a result of the transaction, Weber Darin J. now holds 119,892 shares, worth roughly $0.29 million.
Guggenheim initiated its ProKidney Corp [PROK] rating to a Buy in a research note published on September 10, 2024; the price target was $6. BofA Securities also remained covering PROK and has decreased its forecast on January 02, 2024 with a “Neutral” recommendation from previously “Buy” rating. BTIG Research started covering the stock on July 25, 2023. It rated PROK as “a Buy”.
Price Performance Review of PROK
On Friday, ProKidney Corp [NASDAQ:PROK] saw its stock jump 2.93% to $2.46. Over the last five days, the stock has gained 2.93%. ProKidney Corp shares have risen nearly 38.20% since the year began. Nevertheless, the stocks have fallen -47.55% over the past one year. While a 52-week high of $5.29 was reached on 05/20/24, a 52-week low of $1.12 was recorded on 02/13/24. SMA at 50 days reached $2.28, while 200 days put it at $2.12.
Levels Of Support And Resistance For PROK Stock
The 24-hour chart illustrates a support level at 2.27, which if violated will result in even more drops to 2.07. On the upside, there is a resistance level at 2.60. A further resistance level may holdings at 2.73. The Relative Strength Index (RSI) on the 14-day chart is 56.40, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.04, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 22.00%. Stochastics %K at 72.14% indicates the stock is a holding.
How much short interest is there in ProKidney Corp?
A steep rise in short interest was recorded in ProKidney Corp stocks on 2024-08-30, dropping by -0.25 million shares to a total of 10.1 million shares. Yahoo Finance data shows the prior-month short interest on 2024-07-31 was 10.35 million shares. There was a decline of -2.48%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on December 21, 2022 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $15 price target.
